By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Phoenix RelationsPhoenix RelationsPhoenix Relations
  • Home
  • Categories
    • CrimeUnlimited
    • Economy
    • Education
    • Entertainment
    • HealthHot
    • Exclusives
    • News100+
    • Politics
    • Press Realeases
    • Sports
    • Tech
    • Opinions
  • About
  • Privacy Policy
  • Contact Us
Reading: UK Approves ‘Landmark’ Breast Cancer Drug
Share
Sign In
Notification Show More
Font ResizerAa
Phoenix RelationsPhoenix Relations
Font ResizerAa
Search
  • Home
  • About Us
  • Blog
  • Categories
    • Crime
    • Economy
    • Education
    • Entertainment
    • Health
    • Exclusives
    • News
    • Politics
    • Press Realeases
    • Sports
    • Tech
    • Opinions
  • Contact
  • Privacy Policy
Have an existing account? Sign In
Follow US
  • Advertise
© 2024 Phoenix Relations. All Rights Reserved.
HealthNews

UK Approves ‘Landmark’ Breast Cancer Drug

Phoenix Relations
Last updated: 12 April 2025 06:56
Phoenix Relations
Share
2 Min Read
SHARE

A new drug that helps slow the spread of an incurable type of breast cancer has been approved for use in Britain’s state-run National Health Service, officials said on Friday.

Scientists described the approval of capivasertib by the National Institute for Health and Care Excellence (NICE) as a “landmark moment”.

More than 1,000 women with the HR-positive HER2-negative type of the disease could benefit from taking the twice-daily pill every year, NICE said.

The drug, also known as Truqap and made by British pharmaceutical giant AstraZeneca, helps slow or stop the progression of the cancer, meaning it could help some patients live longer.

“People with advanced breast cancer would value treatments like capivasertib that can be given when limited options exist and because it may delay the need for chemotherapy and its associated side-effects,” said NICE’s director of medicines evaluation, Helen Knight.

The advanced type of the breast cancer has certain genetic mutations and spreads within the breast tissue or to other parts of the body.

The pill works by blocking the action of an abnormal protein that tells cancer cells to multiply.

Results from a clinical trial found that capivasertib plus the hormone therapy fulvestrant increased the time before the cancer worsened by around 4.2 months compared with a placebo and fulvestrant.

The Institute of Cancer Research (ICR) in London welcomed the move, which follows decades of research by its scientists.

“This announcement is a triumph that will improve treatment for these patients with the most common type of advanced breast cancer,” said ICR’s chief executive Kristian Helin.

“Around half of patients with this kind of breast cancer have mutations in one or more of the genes, and for these patients capivasertib can halt disease progression.”

NICE said 40,192 people were diagnosed with breast cancer in 2020, almost 15 percent of whom had advanced stages of the disease when they were diagnosed.

AFP

You Might Also Like

BIGI Backs Emerging Talent as FUNAAB Students Take the Stage at Soundcity OnTour

Zidane names four captains for France Zidane names France captains Mbappé

Army arrests nine suspected drug dealers, hands over illicit drugs to NDLEA in Yobe

Nigeria’s fintechs hit a cross-border wall

After 8 Years in Space, ‘BepiColombo’ Is Finally Approaching Mercury

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.

By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Share This Article
Facebook Twitter Copy Link Print
Share
Previous Article UN Denounces Army Attacks In Myanmar Despite Post-Quake Truce
Next Article Recall: Court Orders Substitution Service For Two Petitioners In Natasha, INEC Case
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

//

We influence 20 million users and we are the number one  news network on the planet

Stay Connected

235.3kFollowersLike
69.1kFollowersFollow
11.6kFollowersPin
56.4kFollowersFollow
136kSubscribersSubscribe
4.4kFollowersFollow
- Advertisement -
Ad imageAd image

Latest News

Nvidia’s board is reportedly ‘not considering’ hiring Jensen
Default Blog 17 November 2026
EU Sanctions Pro-Russian Hacker Group and Propaganda Firm
Press Releases 17 November 2026
Lawyer on the microchip case passcode
Press Releases 17 November 2026
Power Minister Tegbe Reaffirms Tinubu Administration’s Commitment to Improved Electricity Supply
Press Releases 16 November 2026

Technology

  • Advertise with us
  • Terms & Conditions
  • Privacy Policy

Health

  • Advertise

Entertainment

Sign Up for Our Weeky Newsletter

Subscribe to our weekly newsletter to get our newest article/news/articles instantly!

Phoenix RelationsPhoenix Relations
Follow US
© 2024 Phoenix Relations. | All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?